CSCO
63
-4
DE
46
3
COF
67
2
AIZ
59
5
AA
72
3
ADT
48
2
BWA
61
2
AEE
48
-2
DIS
68
4
CA
24
-3
AMAT
54
-3
ALLE
50
9
CMG
50
6
APD
44
9
AVGO
33
-7
ACN
52
-2
AON
62
8
D
35
-2
BRK.B
40
4
CB
64
6
CSCO
63
-4
DE
46
3
COF
67
2
AIZ
59
5
AA
72
3
ADT
48
2
BWA
61
2
AEE
48
-2
DIS
68
4
CA
24
-3
AMAT
54
-3
ALLE
50
9
CMG
50
6
APD
44
9
AVGO
33
-7
ACN
52
-2
AON
62
8
D
35
-2
BRK.B
40
4
CB
64
6
Financhill
Back

Microsoft Corp. Vs. Kymera Therapeutics, Inc. Sector Stock Comparison

Sell
41

MSFT
Microsoft Corp.

Last Price:
$483.65
Seasonality Move:
5.2%
Buy
87

KYMR
Kymera Therapeutics, Inc.

Last Price:
$87.93
Seasonality Move:
10.35%
Sell
41
Microsoft Corp. (MSFT) is a Sell

Is Microsoft Corp. a Buy, Sell or Hold?

  • The current Microsoft Corp. [MSFT] share price is $483.47. The Score for MSFT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • MSFT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
87
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $87.81. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

MSFT Stock Price Chart

What is Microsoft Corp.'s stock price today?

  • The Microsoft Corp. share price today is $483.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MSFT is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $87.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.

MSFT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.05 Sell
Relative Strength Index (14 RSI): 44.19 Sell
Chaikin Money Flow: 12249691 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (478.86 - 502.28) Sell
Bollinger Bands (100): (494.33 - 523.73) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.53 Buy
Relative Strength Index (14 RSI): 71.11 Buy
Chaikin Money Flow: -592960 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.18 - 78.14) Buy
Bollinger Bands (100): (43.11 - 66.09) Buy

MSFT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 484.6 Sell
20-day SMA: 487.22 Sell
50-day SMA: 505.41 Sell
200-day SMA: 471.47 Buy
8-day EMA: 484.75 Sell
20-day EMA: 489.24 Sell
50-day EMA: 498.47 Sell
200-day EMA: 480.77 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 77.75 Buy
20-day SMA: 70.43 Buy
50-day SMA: 63.87 Buy
200-day SMA: 45.05 Buy
8-day EMA: 80.77 Buy
20-day EMA: 72.92 Buy
50-day EMA: 64.9 Buy
200-day EMA: 50.57 Buy

Microsoft Corp. Earnings Growth & MSFT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.59 per share, and an increase next year of $2.81 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.33 per share.

Microsoft Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):